Recommended genotyping procedures (RGPs) to identify parasite populations
Developed after an informal consultation organized by the Medicines for Malaria Venture and cosponsored by the World Health Organization, 29‐31 May 2007, Amsterdam, The Netherlands
In 1996, WHO developed a protocol for assessing the therapeutic efficacy of antimalarial drugs for the treatment of falciparum malaria in intense transmission areas. The protocol was updated to include assessment for low to moderate transmission areas. Due to longer follow-up, genotyping to distingish reinfection and recrudescence has become mandatory. Technical report (below) and recommended genotyping procedures are available.